Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Novo Nordisk on the Verge of Another Blockbuster Drug?
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
Submitted by
admin
on March 19, 2024 - 11:25am
Source:
Motley Fool
News Tags:
Novo Nordisk
amycretin
obesity
Headline:
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
snippet:
Novo Nordisk is enjoying stunning growth thanks to its breakthroughs in diabetes and obesity.
The company is looking to augment its obesity care line with an oral drug called amycretin.
Amycretin just completed phase I clinical trials, and the data showed positive indications.
Do Not Allow Advertisers to Use My Personal information
